SUMMER ROAD LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.

Quarter-by-quarter ownership
SUMMER ROAD LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$19,223
-39.1%
6,122,0890.0%100.00%0.0%
Q2 2023$31,590
-2.1%
6,122,0890.0%100.00%0.0%
Q1 2023$32,263
+87.5%
6,122,0890.0%100.00%0.0%
Q4 2022$17,203
-99.9%
6,122,089
+0.4%
100.00%0.0%
Q3 2022$25,293,000
+5.8%
6,094,761
+2.5%
100.00%0.0%
Q2 2022$23,898,000
-18.8%
5,944,7610.0%100.00%0.0%
Q1 2022$29,427,000
-26.8%
5,944,761
+3.1%
100.00%0.0%
Q4 2021$40,180,000
-28.5%
5,764,761
+2.6%
100.00%0.0%
Q3 2021$56,189,000
-29.5%
5,618,8610.0%100.00%0.0%
Q2 2021$79,675,000
-13.6%
5,618,8610.0%100.00%0.0%
Q1 2021$92,206,000
-20.7%
5,618,8610.0%100.00%0.0%
Q4 2020$116,310,000
+172.0%
5,618,861
+0.0%
100.00%0.0%
Q3 2020$42,756,000
-8.6%
5,618,4240.0%100.00%0.0%
Q2 2020$46,801,000
+79.9%
5,618,424
+6.9%
100.00%
+0.4%
Q1 2020$26,011,000
+73.1%
5,254,788
+38.1%
99.63%
+0.3%
Q4 2019$15,029,000
+29.9%
3,804,7880.0%99.32%
+73.6%
Q3 2019$11,567,000
-30.9%
3,804,7880.0%57.21%
+11.4%
Q2 2019$16,741,000
+10.8%
3,804,7880.0%51.37%
+18.5%
Q1 2019$15,105,000
+0.3%
3,804,788
+0.5%
43.34%
-30.7%
Q4 2018$15,064,000
-27.7%
3,784,850
+25.0%
62.56%
-9.1%
Q3 2018$20,829,000
+1.9%
3,027,4880.0%68.81%
+1.2%
Q2 2018$20,436,000
+3.7%
3,027,4880.0%67.96%
+0.2%
Q1 2018$19,709,0003,027,48867.84%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders